Nurse Practitioner, Family · Barberton, OH
NPI
1457722365
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
201 5th St NE Ste 16
Barberton, OH, 44203
Phone (330) 615-3031
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
1,009 services
Medicare patients, 2024
124
Average age 72
Drug cost, 2024
$1.7M
2,599 prescriptions
Company payments, 2025
$6,999
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melinda R McClellan was code 99214 (office e&m - established), 123 times for 78 patients. In total Melinda R McClellan billed 1,009 services in 8 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 123 | 78 | $70.61 | $8,685 |
| 99213 Office E&M - Established | Office | 49 | 44 | $49.07 | $2,405 |
| 99215 Office E&M - Established | Office | 29 | 27 | $107.42 | $3,115 |
By year: 2022 $15K for 411 services; 2023 $18K for 993 services; 2024 $19K for 1,009 services.
Medicare prescription drug claims, 2024
In 2024, the drug Melinda R McClellan prescribed most often to Medicare patients was Nurtec Odt (Rimegepant Sulfate), with 310 prescriptions and refills. In total Melinda R McClellan wrote 2,599 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nurtec Odt Rimegepant Sulfate | 310 | 322 | 44 | $390K |
| Ubrelvy Ubrogepant | 167 | 178 | 29 | $182K |
| Qulipta Atogepant | 144 | 152 | 19 | $162K |
| Gabapentin Generic | 131 | 224 | 41 | $2,123 |
| Levetiracetam Generic | 131 | 207 | 22 | $2,455 |
| Ropinirole Hcl Generic | 88 | 184 | 28 | $1,595 |
| Amitriptyline Hcl Generic | 77 | 144 | 21 | $1,188 |
| Aimovig Autoinjector Erenumab-Aooe | 73 | 85 | Under 11 | $63K |
| Emgality Pen Galcanezumab-Gnlm | 69 | 93 | 14 | $66K |
| Topiramate Generic | 67 | 129 | 22 | $602 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 66 | 156 | 24 | $2,427 |
| Propranolol Hcl Generic | 58 | 104 | 12 | $1,066 |
| Sumatriptan Succinate Generic | 57 | 69 | Under 11 | $1,200 |
| Duloxetine Hcl Generic | 56 | 102 | 18 | $1,357 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 48 | 109 | 15 | $73K |
Brand drugs: - claims; generic drugs: 1,543 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melinda R McClellan $6,999 ($6,999 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $3,143.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 54 | $3,143 |
| Inspire Medical Systems, Inc. INSP | 15 | $1,749 |
| Biogen, Inc. BIIB | 10 | $374 |
| Eisai Inc. 4523.T | 11 | $265 |
| Teva Pharmaceuticals USA, Inc. TEVA | 29 | $231 |
| Pfizer Inc. PFE | 14 | $218 |
| Lundbeck LLC | 6 | $178 |
| Jazz Pharmaceuticals Inc. JAZZ | 8 | $167 |
| Axsome Therapeutics, Inc. AXSM | 8 | $142 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.